MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Investigation of superficial brain stimulation (SBS) in Parkinsonian rats as a non-invasive alternative treatment for patients with movement disorders

    G. Weistroffer, J. Blagg, M. Tashli, R. Hadimani, D. Kumbhare, M. Baron (Richmond, USA)

    Objective: To investigate repetitive transcranial magnetic stimulation (rTMS) in parkinsonian rats as a non-invasive, malleable superficial brain stimulation (SBS) alternative to DBS. Background: DBS is…
  • 2023 International Congress

    Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

    R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)

    Objective: To describe a rare case of NUS1 gene mutation related progressive epilepsy myoclonus ataxia syndrome. Background: Pathogenic variants of NUS1 gene have been associated…
  • 2023 International Congress

    Oculomotor findings in paraneoplastic neurological syndromes with cerebellar ataxia

    A. Milovanović, I. Basta, N. Kresojević, O. Tamaš, A. Tomić Pešić, I. Stanković Tutuš, M. Svetel, VS. Kostić, NT. Dragašević Mišković (Belgrade, Serbia)

    Objective: This study aimed to evaluate oculomotor disturbances in paraneoplastic cerebellar syndromes. Background: Paraneoplastic cerebellar syndrome is an immune-mediated disorder triggered by neoplastic lesion in…
  • 2023 International Congress

    Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

    V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)

    Objective: The objective of this study is to compare robust neuromelanin (NM) substantia nigra pars compacta (SN) and locus coeruleus (LC) quantification techniques captured in…
  • 2023 International Congress

    Double-blind, randomized, crossover clinical trial to compare VIM vs PSA deep brain stimulation in patients with disabling essential tremor. Preliminary results.

    L. Triguero-Cueva, CJ. Madrid Navarro, MJ. Perez Navarro, B. Iáñez Velasco, M. Jouma Katati, JP. Martínez Barbero, A. Mínguez-Castellanos, F. Escamilla Sevilla (Jódar, Spain)

    Objective: To compare the safety, efficacy, energy efficiency and quality of life (QoL) outcomes of bilateral PSA-DBS vs bilateral VIM-DBS in the treatment of refractory…
  • 2023 International Congress

    Apathy, white-matter microstructure, and effort-based decision making in Parkinson’s Disease

    N. Vanegas-Arroyave, C. Leheron, Z. He, S. Lee, E. Huey, Y. Gazes (Houston, USA)

    Objective: To investigate the influence of reward and effort on behavior in PD patients with and without apathy, using a drift-diffusion model to analyze neuroimage…
  • 2023 International Congress

    Challenges with oral anti-parkinsonian medications and opportunities with continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) for treatment of advanced Parkinson’s Disease (aPD)

    J. Aldred, M. Soileau, C. Yan, T. Brion, A. Bellenger, J. Suh, C. O'Donnell, P. Kukreja, M. Facheris, A. Shewale, R. Kumar (Spokane, USA)

    Objective: To understand people with Parkinson’s (PwP) experience with their advancing disease and identify factors for PwP to initiate and continue on LDP/CDP as treatment…
  • 2023 International Congress

    Spiral Tunneling Technique for passing electrode lead for Deep Brain Stimulation(DBS) surgery in Parkinson’s disease(PD)

    A. Uppar, D. Srinivas (BANGALORE, India)

    Objective: To compare the conventional “Twist & Anti-Twist” technique and “Spiral Tunnelling Technique”(STT) for tunnelling the leads for Deep Brain Stimulation surgery in PD. Background:…
  • 2023 International Congress

    Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

    S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)

    Objective: In the current study, we evaluated a newly developed compound with a 1,3,5-trisubstituted pyrazoline scaffold with an improved PDE5 inhibitory potency as a potential…
  • 2023 International Congress

    Studies on mitochondrial dysfunction in the peripheral blood mononuclear cells in an ethnic Indian population of SCA 12 patients

    S. Ansari, J. Rungta, R. Pal, S. Choudhury, R. Banerjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: We chose important mitochondrial genes such as ndufs5, tim22, fis1, dnm1l to understand the alterations in mitochondrial function in the peripheral blood mononuclear cells…
  • « Previous Page
  • 1
  • …
  • 315
  • 316
  • 317
  • 318
  • 319
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley